The Live Cell Imaging Market Insights And Analysis By Products (Equipment, Consumables, Software), Technology (Fluorescence Recovery After Photobleaching (FRAP), Others), Application (Drug Discovery, Cell Biology, Others), End-User- Forecast Till 2032
Live Cell Imaging Market Size was valued at USD 4.7 billion in 2022 and is projected to grow from USD 5.123 Billion in 2023 to USD 8.7 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.1% during the forecast period (2023 - 2032).
The live cell imaging market refers to the market for technologies and equipment used for studying live cells in real-time. Live cell imaging is an important tool in cellular and molecular biology, allowing researchers to observe cellular processes and interactions in living cells.
The market for live cell imaging includes a variety of products, such as microscopes, imaging software, and cell culture and imaging systems. The market is driven by increasing research activities in the fields of drug discovery, cell biology, and genetics, as well as by the growing demand for advanced imaging technologies in the healthcare industry.
Drivers and Constraints
The extensive application of live cell imaging technology in novel drug research and development is expected to underpin the market rise in the near future. Electronic microscopes and other type of high content screening systems are deployed in studying colossal medical attributes that impact innovations in life science. In addition, the availability of modern medical technologies for enhancing the existing live cell imaging techniques can underpin the expansion of the live cell imaging market through the study period. Under the present circumstance, the live cell imaging is used extensively to aid a cure for COVID 19, which can add momentum to the rise of the live cell imaging market growth. Increase in funding for government cell-based research can also cause escalation of the market revenue through the study period. Other causes that can bolster the rise of the live cell imaging market trends are changing dynamics of the bioscience field, developing economic conditions, and easy access to high quality research equipment and services. At the same time, easy approvals for research from regulatory bodies and rapid spreading of awareness can also foster the live cell imaging market growth. On the flip side, lack of expertise and high prohibitive costs are some primary constraints on the live cell imaging market. However, rise in the utility of live cell imaging solutions across biotech and pharmaceutical domain can counter the market slow-down in the coming years.
The segment assessment of the live cell imaging market are done by products, Consumables, Equipment, and Software.
The technology-based segment of the live cell imaging market are Fluorescence Recovery After Photobleaching, Fluorescence Resonance Energy Transfer, Ratiometric Imaging, High-Content Analysis, Total Internal Reflection Fluorescence Microscopy, Fluorescence in Situ Hybridization, and Multiphoton Excitation Microscopy among other technologies.
The application-based segment of the live cell imaging market are Stem Cells, Cell Biology, Drug Discovery, and Developmental Biology among others.
The End-user based segment of the live cell imaging market trends are Biotechnology Companies, Pharmaceutical Companies, Diagnostic Laboratories, and Hospitals among others.
In North America, the live cell imaging market can earn decent revenue as substantial investments are made in RD activities for pharmaceutical and biotech sectors. Other factors, such as; presence of firm healthcare system and need to treat the increase in cases of difficult-to-treat ailments can support the rise of the market across the review period.
In APAC, capitalization on the easy availability of advanced imaging systems and increase in research to provide better imaging quality and allow efficient functionality of data can foster the rise of live cell imaging market in the years to come.
In EU, the powerful economic conditions of the region allowing the flow of funding required for RD can promote the expansion of the market in the upcoming years. The regions is a house to several renowned live cell imaging solution provider, which can significantly impact the rise of the regional market in the approaching years.
Nikon Corporation (Japan), BioTek Instruments (U.S.), Carl Zeiss AG (Germany), Leica Microsystems (Germany), Sigma-Aldrich Corporation (U.S.), GE Healthcare (U.K.), Olympus Corporation (Japan), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Molecular Devices, LCC (U.S.), Becton, Dickinson and Company (U.S.), and Thermo Fisher Scientific, Inc. (U.S.) are some companies in the live cell imaging market that are profiled by MRFR.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]